Explore healthcare trends, quizzes, tips, web stories, and medical humor in our weekly newsletter, Issue No.112 ...

Vedolizumab outperforms infliximab in ulcerative colitis patients who fail first-line treatment, achieving better ...

Topline clinical data of the confirmatory registrational study GLOW2 expected in 1Q 2026. GLOW2 study design mirrors GLOW1 study, which met primary endpoint and all key secondary ...

HealthTree Foundation, a global nonprofit dedicated to improving outcomes for blood cancer patients through technology-driven soluti ...

On March 8, 2025, the public welfare activity of "Celebrating International Women's Day and Caring for Women's Health" and the "Global Press Conference of E7 Protein Detection Kit" were successfully ...

Want to improve flexibility, balance hormones, and reduce stress? These 7 yoga poses can transform your health! Which one is ...

Sigrid Therapeutics (Sigrid) is excited to announce that it has secured U.S. market access for its proprietary SiPore� technology, following the success of the SHINE study, the largest of its kind in ...

Discover how LC-WGS technology accelerates pathogen detection, offering faster diagnosis and treatment for bloodstream ...

Most of us struggle to figure out the adequate life cover after deciding to buy term insurance plan and may end up under insured.

Haduvio met the primary endpoint with a statistically-significant reduction (p0.0001) in 24-hour cough frequency with a 57% placebo-adjusted change from baseline Company to host a conference call and ...

A new study presented at the 2025 Annual Meeting of the American Academy of Orthopaedic Surgeons�(AAOS) examined the impact of a policy implemented by the United States Soccer Federation (USSF) to ...

Discover the price reduction of ENFINIA™ DNA products by 25%, improving access to high-quality DNA for researchers.